3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
163
Carcinoma, Renal Cell
45
Urinary Bladder Neoplasms
33
Carcinoma, Transitional Cell
19
Lung Neoplasms
14
Melanoma
11
Neoplasm Metastasis
10
Glioma
10
Breast Neoplasms
9
Wilms Tumor
8
Ovarian Neoplasms
8
Carcinoma, Non-Small-Cell Lung
8
Sarcoma
7
Kidney Neoplasms
7
Colorectal Neoplasms
7
Uterine Cervical Neoplasms
6
Ureteral Neoplasms
6
Testicular Neoplasms
6
Rhabdoid Tumor
6
Pancreatic Neoplasms
6
Neuroectodermal Tumors, Primitive, Peripheral
6
Neuroblastoma
6
Medulloblastoma
6
Lymphoma, Non-Hodgkin
6
Histiocytosis, Langerhans-Cell
6
Hepatoblastoma
6
Ependymoma
6
Clear-cell metastatic renal cell carcinoma
6
Carcinoma, Hepatocellular
6
Brain Neoplasms
6
Interventions
Gemcitabine
30
Mitomycin
25
BCG Vaccine
13
Docetaxel
10
Epirubicin
6
erdafitinib
5
durvalumab
5
dodecyl maltoside
5
Radiotherapy
5
Cystoscopy
5
apaziquone
4
ALT-803
4
tislelizumab
3
5-aminolevulinic acid hexyl ester
3
viscum album peptide
2
pembrolizumab
2
disitamab vedotin
2
avelumab
2
VB4-845
2
Therapeutics
2
Imiquimod
2
Hyaluronic Acid
2
Administration, Intravesical
2
1-phenyl-3,3-dimethyltriazene
2
vocimagene amiretrorepvec
1
valrubicin
1
tremelimumab
1
toripalimab
1
pirarubicin
1
pemigatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Non-Muscle Invasive Bladder Neoplasms
×
Magnetic Resonance Spectroscopy
×
Genitourinary
×
Clear all
NCT07000084
2026-06-02
GAIN-BCG
Alliance for Clinical Trials in Oncology
Phase 3
Recruiting
330 enrolled